FILTER BY:
Suboptimal outcomes in patients with retinal vascular diseases receiving i…
Expiration Date: 11/29/2023
Max Credits: 1.25
View Activity
In this continuing medical education activity, experts in the field exami…
Expiration Date: 10/30/2023
Max Credits: 1
Although there have been no additional approvals since voritegene neparvov…
Max Credits: 1.5
Lack of response or suboptimal response in a proportion of patients treate…
Expiration Date: 9/29/2023
Reducing treatment burden in patients receiving intravitreal anti-vascular…
Expiration Date: 9/15/2023
Development of uveitic macular edema (UME) in patients with uveitis is ass…
Expiration Date: 8/18/2023
Intravitreal anti-vascular endothelial growth factor (VEGF) based treatmen…
Expiration Date: 8/11/2023
Treatment burden and suboptimal responses observed in patients receiving i…
Expiration Date: 6/29/2023
Although greatly improved by anti-VEGF therapy, the treatment of patients …
The need to identify alternate molecular targets for the management of ret…
Expiration Date: 5/24/2023